Fate Therapeutics Inc. sell StockNews.com
Start price
28.06.25
/
50%
€0.88
Target price
28.06.26
-
Performance (%)
118.77%
End price
29.06.26
€1.92
Summary
This prediction ended on 29.06.26 with a price of €1.92. The price for Fate Therapeutics Inc. massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has a follow-up prediction for Fate Therapeutics Inc. where he still thinks Fate Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | -4.072% | -4.072% | 119.099% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.78
10.08.25
10.08.25
-
10.08.26
10.08.26
179.27%
31.07.26
31.07.26
Stopped prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
11.05.24
11.05.24
-
11.05.25
11.05.25
-76.44%
12.05.25
12.05.25